Marilyn Smith
Psychiatric/Mental Health, Adult · New Orleans, LANPI 1396134169
Payments from drug & device makers
Across 333 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- Johnson & Johnson$1K
- Alkermes, Inc.$818
- AbbVie$622
- plus $2K from 14 others
What the payments were for
- Food & beverage$8,01999%
- Education$891%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 32 | $1,228 |
| Teva Pharmaceuticals USA, Inc. | 56 | $1,131 |
| Neurocrine Biosciences, Inc. | 47 | $1,052 |
| Johnson & Johnson | 31 | $1,016 |
| Alkermes, Inc. | 35 | $818 |
| AbbVie | 30 | $622 |
| Indivior Inc. | 27 | $590 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $568 |
| Lundbeck LLC | 22 | $282 |
| Dexcom, Inc. | 1 | $124 |
| Sanofi | 1 | $119 |
| Lilly USA, LLC | 1 | $103 |
| Axsome Therapeutics, Inc. | 5 | $85 |
| Boston Scientific | 1 | $71 |
| Gilead | 3 | $65 |
| GRT US Holding, Inc. | 1 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $56 |
| Sunovion Pharmaceuticals Inc. | 3 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Braeburn Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$498
- ABILIFY MAINTENA$454
- LYBALVI$416
- REXULTI$372
- ABILIFY ASIMTUFII$351
- AUSTEDO$243
- DUPIXENT$237
- CAPLYTA$125
- ARISTADA INITIO$124
- DEXCOM G6 TRANSMITTER$124
- UZEDY$122
- VRAYLAR$120
- INVEGA TRINZA$120
- INVEGA SUSTENNA$120
- Austedo XR$110
- MOUNJARO$103
- SPRAVATO$102
How this compares
Too few psychiatric/mental health, adult providers in Louisianato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 64 | $549,946 |
| Austedo XrDeutetrabenazine | 43 | $335,386 |
| Invega TrinzaPaliperidone Palmitate | 26 | $186,257 |
| VraylarCariprazine Hcl | 67 | $109,636 |
| Invega SustennaPaliperidone Palmitate | 33 | $105,939 |
| Abilify MaintenaAripiprazole | 14 | $39,621 |
| RexultiBrexpiprazole | 17 | $39,497 |
| PerserisRisperidone | 12 | $38,393 |
| Risperdal ConstaRisperidone Microspheres | 19 | $23,808 |
| AuvelityDextromethorphan Hbr/Bupropion | 20 | $12,929 |
| Oxcarbazepine | 92 | $9,150 |
| Aripiprazole | 125 | $8,202 |
| TrintellixVortioxetine Hydrobromide | 12 | $6,421 |
| Propranolol Hcl | 205 | $4,363 |
| Quetiapine Fumarate | 214 | $4,345 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,052 | $549,94664 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,131 | $335,38643 claims |
| Johnson & JohnsonInvega Trinza, Invega Sustenna, Risperdal Consta | $1,016 | $316,00478 claims |
| AbbVieVraylar | $622 | $109,63667 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $1,228 | $79,11831 claims |
| Indivior Inc.Perseris | $590 | $38,39312 claims |
| Axsome Therapeutics, Inc.Auvelity | $85 | $12,92920 claims |
| Lilly USA, LLCOlanzapine | $103 | $3,11182 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few psychiatric/mental health, adult providers in Louisianaon file to place this against a meaningful peer group, so we don't.
Other psychiatric/mental health, adult in New Orleans
- Caron SlusserCovington$316
- Dorotha KubrichtClinton$289
- Tonya MonkRuston$161
- Sandra WilliamsPineville$65
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.